Archive | January 2013

Pedro Carvalho (CRG) explains the role of ER in protein control and lipid homeostasis

Pedro Carvalho, from the CRG tries to understand how the cell uses its quality control mechanisms to get rid of proteins that are not functional. He also studies lipid homeostasis. Both functions take place at the Endoplasmic Reticulum (ER). Check out this video to hear him explain his research.

Changes in the brain in patients with ADHD

Attention-Deficit/Hyperactivity Disorder ADHD involves robust alterations in the cortical cerebral mantle, as shown in a recent article by Òscar Vilarroya and colleagues from the Neuroimaging Research Group at the IMIM-Hospital del Mar. These alterations are most prominent in brain regions involved in attention processing, and are more common in the childhood form of the disorder than in the adult one.

brain mara

ADHD is a psychiatric and neurobehavioral disorder characterized by either significant difficulties of inattention or hyperactivity and impulsiveness or a combination of the two. Although it was initially regarded as a disorder exclusive to childhood – affecting about 3 to 5 percent of children globally -, nowadays its prevalence in adulthood is well established.

Previous research on children with ADHD has shown a general reduction of brain volume, but with a proportionally greater reduction in the volume of the left-sided prefrontal cortex.  The researchers at the IMIM have now used  anatomical brain MRI scans to analyse cortical thickness in 41 normal children and 43 children with ADHD, as well as three groups of adult individuals: 31 normal, 31 ADHD patients treated with stimulants and 24 medication-naïve ADHD patients.

The results, published in PLoS One, show several clusters of reduced laminar cortical thickness in ADHD patients in comparison to neurotypical individuals. These differences were primarily located in the dorsal attention network.

Reference:

Hoekzema E, Carmona S, Ramos-Quiroga JA, Fernández VR, Picado M, Bosch R, Soliva JC, Rovira M, Vives Y, Bulbena A, Tobeña A, Casas M, Vilarroya O. Laminar thickness alterations in the fronto-parietal cortical mantle of patients with attention-deficit/hyperactivity disorder. PLoS One. 2012;7(12):e48286

Down syndrome hippocampal defects improved in a mouse model

In a recent work published in Neurobiology of disease, the research groups lead by Mara Dierssen at the CRG and Cristina Fillat, now at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) have joined efforts to find a potential therapeutic target for Down Syndrome (mice).

mice

Down Syndrome (DS), caused by the trisomy of human chromosome 21 (HSA21), is the most common chromosome abnormality in humans. It is typically associated with a delay in cognitive ability, with an average IQ of around 50 in young adults compared with 100 in adults without the condition, as well as with physical growth and a particular set of facial characteristics.

The Ts65Dn mouse is a genetic model for DS with a trisomy of the homologous chromosome in mice. In this model, overexpression of HSA21 homologous genes has been associated with strong visuo-spatial cognitive alterations, ascribed to hippocampal dysfunction. One of these genes is Dyrk1A (Dual specificity tyrosine-phosphorylation-regulated kinase 1A), a candidate gene for DS which seems to play a significant role in a signaling pathway regulating cell proliferation and which may be involved in brain development.

Dierssen, Fillat and colleagues decided to study whether the normalization of the expression levels of Dyrk1A – that is, reducing its expression, which in these mice is double than normal – might correct hippocampal defects in Ts65Dn mice.

They injected adeno-associated viruses containing a short hairpin RNA against Dyrk1A and a Luciferase reporter gene in the hippocampus of 2 months-old Ts65Dn mice. After checking that the injected hippocampi were efficiently transduced (via bioluminescence in vivo imaging, luciferase activity quantification and immunohistochemical analysis) and that the Dyrk1A expression had indeed been normalized at the molecular level, the researchers compared electrophysiological recordings of hippocampal slices from the Ts65Dn injected mice with those from mice injected with an AAV2/1 control virus.

The mice with normalized Dyrk1A levels displayed attenuation of the synaptic plasticity defects of trisomic mice. They also showed partial improvement in their hippocampal-dependent search strategy, as seen in the Morris water maze task – although long-term consolidation of the task was not achieved.

As the authors conclude, these results show Dyrk1A as a critical player in the pathophysiology of DS and define Dyrk1A as a therapeutic target in adult trisomic mice.

Reference:

Altafaj X, Martín E, Ortiz-Abalia J, Valderrama A, Lao-Peregrin C, Dierssen M, Fillat C. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome. Neurobiol Dis. 2012 Dec 4;

%d bloggers like this: